STAMFORD, Conn., July 12 /PRNewswire/ -- Novogen today announced the results of a Phase II clinical trial of its investigational wound healing compound, Glucoprime, in venous stasis ulcers. The trial was conducted in Australia by Novogen subsidiary, Glycotex Inc., which holds the rights to the ...